Highlights
- 1Scientific reports · 2020
- 2Respiratory research · 2021
- 3ERJ open research · 2025
Publications
77 publications
Funding
7 grantsView NIH portfolio on RePORTER ↗
Active
1 grant- PIR01HL171622-01A1Protective effects of metformin against cigarette smoke-induced lung pathologies via regulation of fatty acids metabolismNHLBI · 2024–2028 · via NIH RePORTER
Completed grants (6)
- Co-IW81XWH-20-1-0191Iron chelation therapy for ovarian cancer: reprogramming the tumor microenvironment and the host microbiome to control disease progression.U.S. Department of Defense · 2020–2022
- Co-IR01HL132198-01A1Metabolic Dysfunction Regulates Mitophagy-Dependent Necroptosis in COPDNational Heart, Lung, and Blood Institute · 2017–2021· 2 renewals
- PIR00HL125899-05Mitochondrial Iron Metabolism in Chronic Obstructive Pulmonary DiseaseNational Heart, Lung, and Blood Institute · 2017–2020
- PIACCP 183462-01Extracellular Ferritin as a Biomarker in Chronic Obstructive Pulmonary DiseaseAmerican College of Chest Physicians · 2018–2019
- PIDF 180465-01Development of a Novel Therapeutic Approach to Chronic Obstructive Pulmonary DiseaseDaedalus Fund for Innovation (Weill Cornell) · 2017–2018
- KPP01HL105339-03Functional Genetics of COPD (Project 2)National Heart, Lung, and Blood Institute · 2013–2016 · via The Brigham & Women's Hospital INC
News mentions
1 mentionView all WCM news ↗
- A Step Closer to Understanding Idiopathic Pulmonary FibrosisJuly 29, 2019
Idiopathic pulmonary fibrosis (IPF), a fatal lung disease whose cause has long been a mystery, may be triggered by damage to mitochondria, the tiny oxygen-burning reactors that provide most of a cell’s energy needs, according to a study from scientists at Weill Cornell Medicine.
External relationships
Professional Services
Government of Ireland